SLCO1B1 and myopathy: The analysis of the 32 discovery severe myopathy cases vs. 585 statin‐tolerant controls abolished the rs4149000 genotype association (P = 0.934), as well as for the all myopathy phenotype (P = 0.368) indicating that the two risk alleles are not acting in cis on the same haplotype and that the SLCO1A2 association is not acting independently of SLCO1B1.